Atrial Fibrillation Market is Expected to Reach USD 14.8 Billion Globally in 2019: Transparency Market Research

ALBANY, New York, October 9, 2013 /PRNewswire/ --

According to a new market report published by Transparency Market Research "Atrial Fibrillation Market (Pharmacological and Non-Pharmacological Treatment, Electric Cardioversion, Radiofrequency, Cryo, Laser and Microwave Catheter Ablation, Maze Surgery, Anti-Coagulant and Anti-Arrhythmic Drugs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global market for atrial fibrillation was valued at USD 6.1 billion in 2012 and it is expected to reach an estimated value of USD 14.8 billion in 2019, growing at a CAGR of 13.4% from 2013 to 2019.

Browse the full report with Complete TOC at http://www.transparencymarketresearch.com/atrial-fibrillation-market.html

Rising global base of geriatric population inducing an accelerated growth in the incidence rates of atrial fibrillation is one of the highest impact-rendering drivers for this market. In addition, favorable results exhibited by clinical trials promoting combined pharmacological therapy such as the HARMONY trial and rising prevalence of disorders causing atrial fibrillation such as hypertension and obesity will also serve the market as drivers. The future growth of this market will be ensured by the introduction of advanced treatment procedures such as hybrid ablation and the rising prevalence of atrial fibrillation in emerging Asian economies.

On account of the fact that pharmacological treatment procedures are more frequently administered to the patients suffering from atrial fibrillation and are a cheaper alternative to non-pharmacological procedures, pharmacological procedures held the majority of market share in 2012. With the introduction of new drugs such as Bristol Myer Squibb's NTC-801, Merck's Vernakalant, Boehringer Ingelheim's Pradaxa, the market share of pharmacological treatment procedures is expected to further increase by 2019.

The non-pharmacological treatment market was led by the catheter ablation market and its market share was valued at over 45% in 2012. The introduction of new catheter ablation systems such as CardioFocus's HeartLight Endoscopic Ablation System (EAS) laser ablation catheter, Endosense's TactiCath and Biosense Webster's ThermoCool SmartTouch, will help the catheter ablation market to further enhance its market share by 2019.

The radiofrequency based catheter ablation treatment for atrial fibrillation market led the catheter ablation market in terms of market share in 2012 majorly on account of the facts that it has a relatively lower procedural duration and cost and has high success rates associated with it.

High prevalence of atrial fibrillation coupled with the availability of high disposable incomes amongst patients and sophisticated healthcare infrastructure, has led the North American atrial fibrillation market to hold the majority of the market share in 2012. However, this region is expected to lose its market share to relatively faster growing Asia-Pacific region.

Some of the key players of this market include Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer, Bayer/Johnson & Johnson, Medtronic, Inc., St. Jude Medical, Inc. and AtriCure, Inc.

Related & Recently Published Reports by Transparency Market Research

• Transcriptomics Technologies Market: http://www.transparencymarketresearch.com/transcriptomics-technologies-market.html
• Freeze Drying Equipment Market: http://www.transparencymarketresearch.com/freeze-drying-equipment-market.html
• Metal Cans Market: http://www.transparencymarketresearch.com/metal-cans-market.html

The global atrial fibrillation market is categorized into the following segments:

• Atrial Fibrillation Market, by Treatment Types
  • Pharmacological Treatment
    • Anti-Arrhythmic Drugs
    • Anti-Coagulant Drugs
  • Non-Pharmacological Treatment
    • Catheter Ablation
      • Radiofrequency Based
      • Cryoablation Based
      • HIFU (High Intensity Focused Ultrasound) Based
      • Microwave Based
      • Laser Based
    • Maze Surgery
    • Electric Cardioversion
• Atrial Fibrillation Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html 

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Visit: http://www.transparencymarketresearch.com/
Visit: http://tmralbany.wordpress.com/

SOURCE http://www.transparencymarketresearch.com